Nutriband Signs Trademark Licensing Agreement For Bitrex Brand Denatonium Benzoate, As An Aversive Agent For Its Aversa Fentanyl Abuse Deterrent Fentanyl Transdermal Patch
Portfolio Pulse from Nabaparna Bhattacharya
Nutriband has signed a trademark licensing agreement for Bitrex brand Denatonium Benzoate to be used as an aversive agent in its Aversa Fentanyl Abuse Deterrent Transdermal Patch. This technology aims to deter oral abuse and accidental exposure to opioid and stimulant patches.
September 20, 2024 | 10:57 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Nutriband's new licensing agreement for Bitrex enhances its Aversa Fentanyl Abuse Deterrent Patch, potentially increasing its market appeal and addressing safety concerns.
The licensing agreement for Bitrex, a well-known aversive agent, strengthens Nutriband's product offering by enhancing the safety profile of its Aversa Fentanyl Patch. This could lead to increased adoption and market share, positively impacting the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90